Compare Abbott India with Piramal Healthcare - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs PIRAMAL ENTERPRISES - Comparison Results

ABBOTT INDIA     Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

PIRAMAL ENTERPRISES 
   Change

Piramal Enterprises has a presence in custom manufacturing, critical care OTC and financial services. To give a boost to its custom manufacturing operations, the company had acquired Avecia Pharmaceuticals, UK in 2005 and Pfizer's Morpeth facility in... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA PIRAMAL ENTERPRISES ABBOTT INDIA/
PIRAMAL ENTERPRISES
 
P/E (TTM) x 56.2 16.9 333.2% View Chart
P/BV x 13.6 1.1 1,210.7% View Chart
Dividend Yield % 0.5 1.6 32.0%  

Financials

 ABBOTT INDIA   PIRAMAL ENTERPRISES
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-19
PIRAMAL ENTERPRISES
Mar-19
ABBOTT INDIA/
PIRAMAL ENTERPRISES
5-Yr Chart
Click to enlarge
High Rs8,8343,303 267.5%   
Low Rs5,4581,797 303.7%   
Sales per share (Unadj.) Rs1,731.1716.5 241.6%  
Earnings per share (Unadj.) Rs211.979.7 265.9%  
Cash flow per share (Unadj.) Rs219.9107.9 203.8%  
Dividends per share (Unadj.) Rs65.0028.00 232.1%  
Dividend yield (eoy) %0.91.1 82.8%  
Book value per share (Unadj.) Rs945.21,477.5 64.0%  
Shares outstanding (eoy) m21.25184.45 11.5%   
Bonus/Rights/Conversions -IS-  
Price / Sales ratio x4.13.6 116.0%   
Avg P/E ratio x33.732.0 105.4%  
P/CF ratio (eoy) x32.523.6 137.5%  
Price / Book Value ratio x7.61.7 438.1%  
Dividend payout %30.735.1 87.3%   
Avg Mkt Cap Rs m151,848470,292 32.3%   
No. of employees `0003.57.8 44.6%   
Total wages/salary Rs m4,35622,504 19.4%   
Avg. sales/employee Rs Th10,555.516,899.4 62.5%   
Avg. wages/employee Rs Th1,249.92,877.7 43.4%   
Avg. net profit/employee Rs Th1,292.21,879.9 68.7%   
INCOME DATA
Net Sales Rs m36,786132,153 27.8%  
Other income Rs m1,1333,128 36.2%   
Total revenues Rs m37,919135,281 28.0%   
Gross profit Rs m6,04766,290 9.1%  
Depreciation Rs m1695,202 3.3%   
Interest Rs m2344,097 0.1%   
Profit before tax Rs m6,98920,119 34.7%   
Minority Interest Rs m03,194 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,4858,611 28.9%   
Profit after tax Rs m4,50314,701 30.6%  
Gross profit margin %16.450.2 32.8%  
Effective tax rate %35.642.8 83.1%   
Net profit margin %12.211.1 110.0%  
BALANCE SHEET DATA
Current assets Rs m27,610122,742 22.5%   
Current liabilities Rs m8,569310,810 2.8%   
Net working cap to sales %51.8-142.3 -36.4%  
Current ratio x3.20.4 815.9%  
Inventory Days Days6023 261.0%  
Debtors Days Days2739 70.5%  
Net fixed assets Rs m1,057116,904 0.9%   
Share capital Rs m213369 57.6%   
"Free" reserves Rs m19,873272,161 7.3%   
Net worth Rs m20,086272,530 7.4%   
Long term debt Rs m0270,196 0.0%   
Total assets Rs m29,409856,261 3.4%  
Interest coverage x311.61.5 21,397.7%   
Debt to equity ratio x01.0 0.0%  
Sales to assets ratio x1.30.2 810.5%   
Return on assets %15.46.9 224.1%  
Return on equity %22.45.4 415.6%  
Return on capital %34.912.4 281.0%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m36915,200 2.4%   
Fx outflow Rs m4,9184,889 100.6%   
Net fx Rs m-4,54910,312 -44.1%   
CASH FLOW
From Operations Rs m4,991-115,975 -4.3%  
From Investments Rs m-2,570-8,265 31.1%  
From Financial Activity Rs m-1,428107,525 -1.3%  
Net Cashflow Rs m993-16,650 -6.0%  

Share Holding

Indian Promoters % 0.0 52.9 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 7.9 4.0 197.5%  
FIIs % 0.1 26.6 0.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.1 16.5 103.6%  
Shareholders   18,270 93,274 19.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   AUROBINDO PHARMA  PROCTER & GAMBLE HEALTH  NOVARTIS  FULFORD INDIA  ORCHID PHARMA LTD  

Compare ABBOTT INDIA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Continue Momentum; Sensex Trades 186 Points Higher(12:30 pm)

Share markets in India are presently trading on a strong note. Sectoral indices are trading on a mixed note with stocks in the telecom sector.

Related Views on News

IPCA LABS at All Time High; BSE HEALTHCARE Index Up 0.5% (Market Updates)

Nov 19, 2019 | Updated on Nov 19, 2019

IPCA LABS share price has hit an all time high at Rs 1,182 (up 1.1%). The BSE HEALTHCARE Index is up by 0.5%. Among the top gainers in the BSE HEALTHCARE Index today are IPCA LABS (up 1.1%) and ABBOTT INDIA (up 0.2%). The top losers include SUN PHARMA ADV. RES. and DISHMAN CARBOGEN AMCIS LTD .

PIRAMAL ENTERPRISES Announces Quarterly Results (2QFY20); Net Profit Up 16.5% (Quarterly Result Update)

Oct 25, 2019 | Updated on Oct 25, 2019

For the quarter ended September 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 6 bn (up 16.5% YoY). Sales on the other hand came in at Rs 36 bn (up 14.6% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

ABBOTT INDIA Announces Quarterly Results (1QFY20); Net Profit Up 41.9% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 41.9% YoY). Sales on the other hand came in at Rs 10 bn (up 18.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

PIRAMAL ENTERPRISES Announces Quarterly Results (1QFY20); Net Profit Up 390.0% (Quarterly Result Update)

Aug 1, 2019 | Updated on Aug 1, 2019

For the quarter ended June 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 4 bn (up 390.0% YoY). Sales on the other hand came in at Rs 35 bn (up 20.8% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

PIRAMAL ENTERPRISES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 9, 2019 | Updated on Jul 9, 2019

Here's an analysis of the annual report of PIRAMAL ENTERPRISES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of PIRAMAL ENTERPRISES. Also includes updates on the valuation of PIRAMAL ENTERPRISES.

More Views on News

Most Popular

Crash Alert! Is There a Big Bubble in Nestle, HUL and Asian Paints?(Profit Hunter)

Nov 7, 2019

Is this the beginning of the end of multibagger gains in quality stocks like Nestle, HUL, and Asian Paints?

Why Moody's Rating Downgrade is a Strong Sign to Buy Stocks(The 5 Minute Wrapup)

Nov 8, 2019

Investors who took cues from Moody's rating downgrade in 1992 and 2002 created some of the biggest wealth of their lifetime.

The Smartest Stock to Buy for 2020(Profit Hunter)

Nov 14, 2019

Small-cap stocks are selling at bargain prices today and are poised to generate a lot of wealth in 2020 and beyond...

A Trade that Could Generate Profits for Decades

Nov 14, 2019

India's #1 trader is back on the Investor Hour. Vijay Bhambwani talks to us about his super-profitable trading system and shares with us his #1 long term trade. Listen in...

The One Trade I'm Most Bullish on Now

Nov 12, 2019

A highly specific trade to potentially triple your money in just three months. You won't find this information anywhere else!

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


Nov 19, 2019 01:01 PM

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA 8-QTR ANALYSIS

COMPARE ABBOTT INDIA WITH

MARKET STATS